Drug data last refreshed 14h ago · AI intelligence enriched 1mo ago
AVAGARD is a topical antiseptic solution combining chlorhexidine gluconate and alcohol for rapid microbial reduction on skin. It is indicated for healthcare worker hand hygiene and surgical site preparation to reduce bacterial colonization. The dual-agent formulation provides broad-spectrum antimicrobial activity through chlorhexidine's persistent effect and alcohol's rapid kill kinetics.
Product is in late-stage lifecycle with moderate competitive pressure (30), suggesting stable but contracted commercial infrastructure and potential headcount rationalization.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Working on AVAGARD offers experience in a mature, stable topical antiseptic portfolio within a commodity-dominated space; roles emphasize commercial execution, customer retention, and operational efficiency rather than innovation or expansion. This product is ideal for professionals seeking hands-on sales and marketing experience in hospital/institutional channels with lower technical complexity.
Worked on AVAGARD at Solventum? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.